Regeneron Pharmaceuticals (REGN) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.25% |
| Dec 31, 2025 | 9.03% |
| Sep 30, 2025 | 25.18% |
| Jun 30, 2025 | -19.02% |
| Mar 31, 2025 | 6.15% |
| Dec 31, 2024 | 7.51% |
| Sep 30, 2024 | 27.17% |
| Jun 30, 2024 | -28.48% |
| Mar 31, 2024 | 12.50% |
| Dec 31, 2023 | 24.07% |
| Sep 30, 2023 | 29.83% |
| Jun 30, 2023 | -23.88% |
| Mar 31, 2023 | 17.55% |
| Dec 31, 2022 | 7.17% |
| Sep 30, 2022 | 19.02% |
| Jun 30, 2022 | 22.87% |
| Mar 31, 2022 | 22.95% |
| Dec 31, 2021 | 0.59% |
| Sep 30, 2021 | 2.36% |
| Jun 30, 2021 | 6.36% |
| Mar 31, 2021 | -6.40% |
| Dec 31, 2020 | -1.91% |
| Sep 30, 2020 | 0.95% |
| Jun 30, 2020 | -11.55% |
| Mar 31, 2020 | 8.30% |
| Dec 31, 2019 | 3.41% |
| Sep 30, 2019 | 8.82% |
| Jun 30, 2019 | 5.95% |
| Mar 31, 2019 | 2.77% |
| Dec 31, 2018 | 4.39% |
| Sep 30, 2018 | 27.36% |
| Jun 30, 2018 | 26.59% |
| Mar 31, 2018 | 30.22% |
| Dec 31, 2017 | 47.99% |
| Sep 30, 2017 | 42.23% |
| Jun 30, 2017 | 33.63% |
| Mar 31, 2017 | 35.48% |
| Dec 31, 2016 | 67.85% |
| Sep 30, 2016 | 67.85% |
| Jun 30, 2016 | 56.34% |
| Mar 31, 2016 | 36.25% |
| Dec 31, 2015 | 40.68% |
| Sep 30, 2015 | 45.89% |
| Jun 30, 2015 | 60.42% |
| Mar 31, 2015 | 38.08% |
| Dec 31, 2014 | 39.42% |
| Sep 30, 2014 | 29.00% |